Recombinant Human Anti-CD28 x Human Anti-HN Bispecific Antibody (scFv-Fc) (BSCFV-H237)

Recombinant Anti-CD28 x Anti-HN Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-CD28 specificity or anti-HN specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the tumor vaccine modification and the research of Tumors therapy.

Datasheet INQUIRY

Specifications

Targets

CD28 & HN

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising preventive/therapeutic agent

Related Disease

Tumors

Targets

Target 1

CD28

Gene ID

940

UniProt ID

P10747

Alternative Names

CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen

Target 2

Gene ID

912270

UniProt ID

Q9Q2W5

Alternative Names

Hemagglutinin-neuraminidase; HN

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD28 x Human Anti-HN Bispecific Antibody (scFv-Fc) (BSCFV-H237). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CD28 x Human Anti-HN Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-H237)

Specifications

Targets

Customer Reviews and Q&As